Short-term cotherapy with clonazepam and fluoxetine: Anxiety, sleep disturbance and core symptoms of depression

Journal of Affective Disorders

Volumn 61, Issue 1-2, 2000, Pages 73-79

  Londborg, Peter D ^a,b   Smith, Ward T ^a,b   Glaudin, Vincent ^a,b   Painter, John R ^a,b  

^a Summit Research Network   (United States)

^b Summit Research Network   (United States)

Author keywords

Augmentation; Clonazepam; Cotherapy; Drug therapy; Fluoxetine; Major depression; Side effects (drug)

Indexed keywords

CLONAZEPAM; FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; DRUG SAFETY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SLEEP DISORDER; XEROSTOMIA;

ADULT; AGED; ANXIETY; CLONAZEPAM; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; GABA MODULATORS; HUMANS; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; SLEEP DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034548674     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00195-0     Document Type: Article

References (33)

1. Association of road-traffic accidents with benzodiazepine use
2. The Hamilton depression scale. Evaluation of objectivity using logistic models
3. Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants
4. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression
5. The use of anti-depressants and benzodiazepines in the perpetrators and victims of accidents
6. Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: Alprazolam, adinazolam, and clonazepam
7. Comparison of alprazolam, imipramine, and placebo in the treatment of depression
8. Development of a rating scale for primary depressive illness
9. Benzodiazepine use and the risk of motor vehicle crash in the elderly
10. Augmentation strategies: Focus on anxiolytics
11. Antidepressant noncompliance as a factor in the discontinuation syndrome
12. Psychoactive medications and injurious motor vehicle collisions involving older drivers
13. Benzodiazepines as antidepressants: Does GABA play a role in depression?
14. Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression
15. Comparison of two dosage regimens of fluoxetine in major depression
16. Buspirone in major depression: A controlled study
17. Medications and chronic diseases as risk factors for falling injuries in the elderly
18. An update of the use of benzodiazepines in depressed patients
19. Double-blind efficacy and safety study comparing adinazolam mesylate and placebo in depressed inpatients
20. Long-term open-label study of adinazolam in depressed outpatients
21. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: A double-blind study
22. How to manage anxious patients who are depressed
23. The potential benefits of serotonin receptor-specific agents
24. Anxiolytic antidepressant augmentation
25. Introduction: Augmentation of antidepressant medications
26. Treatment resistant depression